These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 3875509)
1. Suppression of lymphocyte activation by plasma lipoproteins: modulation by cell number and type. Okano Y; Macy M; Cardin AD; Harmony JA Exp Cell Biol; 1985; 53(4):199-212. PubMed ID: 3875509 [TBL] [Abstract][Full Text] [Related]
2. Accessory cells reduce lipoprotein suppression of lymphocyte activation. Okano Y; Macy M; Harmony JA Biochim Biophys Acta; 1985 Apr; 845(1):68-80. PubMed ID: 3872136 [TBL] [Abstract][Full Text] [Related]
3. Plasma lipoproteins can suppress accessory cell function and consequently suppress lymphocyte activation. Nakayasu T; Macy M; Okano Y; McCarthy BM; Harmony JA Exp Cell Res; 1986 Mar; 163(1):103-16. PubMed ID: 2935417 [TBL] [Abstract][Full Text] [Related]
4. Suppression of lymphocyte activation by plasma lipoproteins. Macy M; Okano Y; Cardin AD; Avila EM; Harmony JA Cancer Res; 1983 May; 43(5 Suppl):2496s-2502s. PubMed ID: 6600967 [TBL] [Abstract][Full Text] [Related]
5. Immunoregulation by low density lipoproteins in man. Inhibition of mitogen-induced T lymphocyte proliferation by interference with transferrin metabolism. Cuthbert JA; Lipsky PE J Clin Invest; 1984 Apr; 73(4):992-1003. PubMed ID: 6323541 [TBL] [Abstract][Full Text] [Related]
6. Membrane receptors for very low density lipoprotein (VLDL) inhibitor of lymphocyte proliferation. Yi PI; Beck G; Zucker S Blood; 1981 Jun; 57(6):1055-64. PubMed ID: 6261857 [TBL] [Abstract][Full Text] [Related]
7. Plasma lipoproteins and transferrin regulate the proliferation of a continuous T lymphocyte cell line. McCarthy BM; Okano Y; Nakayasu T; Macy M; Watson SR; Harmony JA J Lipid Res; 1987 Sep; 28(9):1067-77. PubMed ID: 3498779 [TBL] [Abstract][Full Text] [Related]
8. Rat plasma lipoprotein inhibitors of lymphocyte proliferation: specific membrane receptor for very low density lipoproteins. Yi PI; Beck G; Zucker S Int Arch Allergy Appl Immunol; 1981; 65(1):8-14. PubMed ID: 7216515 [TBL] [Abstract][Full Text] [Related]
9. Effect of sirolimus on the metabolism of apoB100- containing lipoproteins in renal transplant patients. Hoogeveen RC; Ballantyne CM; Pownall HJ; Opekun AR; Hachey DL; Jaffe JS; Oppermann S; Kahan BD; Morrisett JD Transplantation; 2001 Oct; 72(7):1244-50. PubMed ID: 11602850 [TBL] [Abstract][Full Text] [Related]
10. [Changes in the rosette-forming capacity of peripheral blood lymphocytes in patients with ischemic heart disease after administration of atherogenic lipoproteins]. Vasil'chenko EM; Beĭko VA; Tymchishin PN; Karpov RS Kardiologiia; 1989 Feb; 29(2):53-6. PubMed ID: 2786106 [TBL] [Abstract][Full Text] [Related]
11. Cocaine suppresses proliferation of phytohemagglutinin-activated human peripheral blood T-cells. Klein TW; Matsui K; Newton CA; Young J; Widen RE; Friedman H Int J Immunopharmacol; 1993 Jan; 15(1):77-86. PubMed ID: 8432625 [TBL] [Abstract][Full Text] [Related]
12. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux. Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475 [TBL] [Abstract][Full Text] [Related]
13. The regulation by low-density lipoproteins of the activation of oxidative enzyme-primed lymphocytes is governed by transferrin. Scupham DW; McCarthy BM; Harmony JA Cell Immunol; 1987 Sep; 108(2):378-95. PubMed ID: 3497727 [TBL] [Abstract][Full Text] [Related]
14. The phosphatidylinositol response and proliferation of oxidative enzyme-activated human T lymphocytes: suppression by plasma lipoproteins. Akeson AL; Scupham DW; Harmony JA J Lipid Res; 1984 Nov; 25(11):1195-205. PubMed ID: 6335165 [TBL] [Abstract][Full Text] [Related]
15. Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects. Cohn JS; Tremblay M; Amiot M; Bouthillier D; Roy M; Genest J; Davignon J Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):149-59. PubMed ID: 8548416 [TBL] [Abstract][Full Text] [Related]
16. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E. Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028 [TBL] [Abstract][Full Text] [Related]
17. Recent progress in the development of radioimmunoassays for human serum lipoproteins. Karlin JB; Juhn DJ; Goldberg R; Rubenstein AH Ann Clin Lab Sci; 1978; 8(2):142-54. PubMed ID: 205163 [TBL] [Abstract][Full Text] [Related]
18. Immunoregulation by low density lipoproteins in man: low density lipoprotein inhibits mitogen-stimulated human lymphocyte proliferation after initial activation. Cuthbert JA; Lipsky PE J Lipid Res; 1983 Nov; 24(11):1512-24. PubMed ID: 6197501 [TBL] [Abstract][Full Text] [Related]
19. Involvement of lipoproteins in suppression of interleukin 2-dependent cell proliferation by sera from aged humans. Ohtsuka Y; Kobayashi K; Hirano T; Furukawa S; Nagano S; Takahashi T Gerontology; 1990; 36(5-6):268-75. PubMed ID: 2150198 [TBL] [Abstract][Full Text] [Related]
20. The significance of apolipoprotein E structure to the metabolism of plasma triglyceride-rich lipoproteins. Dergunov AD; Rosseneu M Biol Chem Hoppe Seyler; 1994 Aug; 375(8):485-95. PubMed ID: 7811390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]